APA (7th ed.) Citation

AD, B., M, L., C, D., K, G., L, N., S, T., . . . P, K. (2010). SCH 2047069, a novel oral kinesin spindle protein inhibitor, shows single-agent antitumor activity and enhances the efficacy of chemotherapeutics. Molecular cancer therapeutics, 9(11), 2993. https://doi.org/10.1158/1535-7163.MCT-10-0548

Chicago Style (17th ed.) Citation

AD, Basso, et al. "SCH 2047069, a Novel Oral Kinesin Spindle Protein Inhibitor, Shows Single-agent Antitumor Activity and Enhances the Efficacy of Chemotherapeutics." Molecular Cancer Therapeutics 9, no. 11 (2010): 2993. https://doi.org/10.1158/1535-7163.MCT-10-0548.

MLA (9th ed.) Citation

AD, Basso, et al. "SCH 2047069, a Novel Oral Kinesin Spindle Protein Inhibitor, Shows Single-agent Antitumor Activity and Enhances the Efficacy of Chemotherapeutics." Molecular Cancer Therapeutics, vol. 9, no. 11, 2010, p. 2993, https://doi.org/10.1158/1535-7163.MCT-10-0548.